Literature DB >> 3265432

Association of HLA-DR2 antigen with serum IgG antibodies against Borrelia burgdorferi in Bannwarth's syndrome.

J H Wokke1, P A van Doorn, A Brand, G M Schreuder, M Vermeulen.   

Abstract

The frequency of the HLA-DR2 antigen in 33 patients with clinical symptoms and signs of Bannwarth's syndrome was 33%, which was not significantly different from the 29% occurrence in 505 control subjects. However, all 11 HLA-DR2-positive patients had elevated serum levels of IgG antibodies against Borrelia burgdorferi, and these were present in 45% of 22 HLA-DR2-negative patients (P = 0.004). In the 21 patients with anti-B. burgdorferi antibodies the frequency of HLA-DR2 was 52%, which is significantly higher than the frequency in the control group (P = 0.04). The diagnosis of Bannwarth's syndrome was serologically confirmed by a positive indirect immunofluorescence assay (IFA). A negative test result does not exclude the diagnosis, as has recently been demonstrated with more sensitive techniques. The association between HLA-DR2 and a positive IFA suggests that the IFA selects a subgroup of patients with Bannwarth's syndrome and a different immune response. We could not demonstrate differences in the clinical spectrum and outcome between the two groups.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265432     DOI: 10.1007/bf00314484

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  HLA-DR in Lyme borreliosis.

Authors:  W Kristoferistsch; W R Mayr; H Partsch; R Neumann; G Stanek
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

2.  [Lymphocytic meningoradiculitis following insect bites (Bannwarth' syndrome)].

Authors:  J H Wokke; J A Vanneste; M Vermeulen; A A Op de Coul; H C Overbeek; R M Janssen; R Brouwers
Journal:  Ned Tijdschr Geneeskd       Date:  1984-09-22

3.  The spirochetal etiology of Lyme disease.

Authors:  A C Steere; R L Grodzicki; A N Kornblatt; J E Craft; A G Barbour; W Burgdorfer; G P Schmid; E Johnson; S E Malawista
Journal:  N Engl J Med       Date:  1983-03-31       Impact factor: 91.245

4.  HLA-DR in meningopolyneuritis of Garin-Bujadoux-Bannwarth: contrast to Lyme disease?

Authors:  W Kristoferitsch; W R Mayr
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

5.  Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.

Authors:  A C Steere; S E Malawista; J A Hardin; S Ruddy; W Askenase; W A Andiman
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

6.  Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis.

Authors:  A C Steere; A Gibofsky; M E Patarroyo; R J Winchester; J A Hardin; S E Malawista
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

7.  Multiple mononeuritis and radiculitis with erythema, pain, elevated CSF protein and pleocytosis (Bannwarth's syndrome).

Authors:  C H Wulff; K Hansen; P Strange; W Trojaborg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

8.  Chronic muscle weakness caused by Borrelia burgdorferi meningoradiculitis.

Authors:  J H Wokke; J de Koning; G Stanek; F G Jennekens
Journal:  Ann Neurol       Date:  1987-09       Impact factor: 10.422

9.  Chronic forms of Borrelia burgdorferi infection of the nervous system.

Authors:  J H Wokke; J van Gijn; A Elderson; G Stanek
Journal:  Neurology       Date:  1987-06       Impact factor: 9.910

10.  The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.

Authors:  A R Pachner; A C Steere
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

View more
  2 in total

1.  Borrelia burgdorferi infection in Europe: an HLA-related disease?

Authors:  C D Reimers; U Neubert; W Kristoferitsch; K H Pflüger; W R Mayr
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

2.  Acute and chronic neuroborreliosis with and without CNS involvement: a clinical, MRI, and HLA study of 27 cases.

Authors:  H Krüger; E Heim; B Schuknecht; S Scholz
Journal:  J Neurol       Date:  1991-08       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.